Lydia M. Evans
- Immunology top 10%
- Pathology and Forensic Medicine top 5%
- Oncology
- Dermatology top 2%
- Epidemiology
- Co-authors
- Loretta M. ItriJohn W. SmithRonald G. SteisWalter J. UrbaDan L. LongoJeffrey W. ClarkMarc E. GrossmanKaren L. Kaul
- Topics
- Chronic Lymphocytic Leukemia Research (5 papers)Lymphoma Diagnosis and Treatment (5 papers)Viral-associated cancers and disorders (4 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologyJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesSwitzerland
In The Last Decade
Lydia M. Evans
16 papers receiving 612 citations
Peers
Comparison fields: 5 of 53
- Immunology 259
- Pathology and Forensic Medicine 242
- Oncology 200
- Dermatology 191
- Epidemiology 141
Countries citing papers authored by Lydia M. Evans
This map shows the geographic impact of Lydia M. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia M. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia M. Evans more than expected).
Fields of papers citing papers by Lydia M. Evans
This network shows the impact of papers produced by Lydia M. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia M. Evans. The network helps show where Lydia M. Evans may publish in the future.
Co-authorship network of co-authors of Lydia M. Evans
This figure shows the co-authorship network connecting the top 25 collaborators of Lydia M. Evans. A scholar is included among the top collaborators of Lydia M. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia M. Evans. Lydia M. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 26 | |
| 3 | 1 | |
| 4 | 20 | |
| 5 | 47 | |
| 6 | 23 | |
| 7 | 58 | |
| 8 | Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia. | 38 |
| 9 | 95 | |
| 10 | 17 | |
| 11 | Interferon-alpha and interleukin-2 in the treatment of renal cell cancer. | 2 |
| 12 | 66 | |
| 13 | Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a. | 26 |
| 14 | 186 | |
| 15 | Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma. | 22 |
| 16 | 2 |
About Lydia M. Evans
Lydia M. Evans is a scholar working on Genetics, Dermatology and Immunology, having authored 16 papers that have together received 641 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Dermatology (191 citations), Pathology and Forensic Medicine (242 citations) and Immunology (259 citations). Lydia M. Evans has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Loretta M. Itri, John W. Smith, Ronald G. Steis, Walter J. Urba, Dan L. Longo, Jeffrey W. Clark, Marc E. Grossman, Karen L. Kaul, Daina Variakojis and Elizabeth A. Springer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.